MedTrace Logo

Dialysis Training Therapy: The DiaTT Trial

NCT03885102 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1211

Last updated 2022-12-02

No results posted yet for this study

Summary

DiaTT is an interventional, cluster-randomized (1:1), multicenter trial for patients with chronic kidney disease undergoing hemodialysis (n=1,100). This trial will test the effectiveness (by change of sit-to-stand test between baseline and 12 months) of intradialytic exercise training (ET) and health literacy counseling (HLC) for 12 months (Intervention group) in comparison to control group (usual care, UC; no ET, no HLC).

Conditions

  • Chronic Kidney Diseases
  • Hemodialysis

Interventions

BEHAVIORAL

Intradialytic exercise intervention

50% aerobic exercise, 50% resistance training thrice a week for 60 min per dialysis session, and health literacy counselling

BEHAVIORAL

Usual Care

Usual care with no exercise intervention or health literacy counselling

Sponsors & Collaborators

  • Technical University of Munich

    collaborator OTHER

  • University Hospital of Cologne

    collaborator OTHER

  • KfH Kuratorium für Dialyse und Nierentransplantation

    collaborator UNKNOWN

  • Clinical Trials Unit Freiburg

    collaborator OTHER

  • AOK PLUS

    collaborator INDUSTRY

  • BARMER

    collaborator OTHER

  • Techniker Krankenkasse

    collaborator OTHER

  • Federal Joint Committee

    collaborator OTHER_GOV

  • Prof. Dr. med. Martin Halle

    lead OTHER

Principal Investigators

  • Gabriele Ihorst, PhD · Clinical Trials Unit Freiburg, Medical Center, University of Freiburg

  • Gero von Gersdorff, MD · Department II of Internal Medicine, University of Cologne

  • Kirsten Anding-Rost, MD · KfH Kuratorium für Dialyse und Nierentransplantation e.V.

  • Martin Halle, Prof. MD · Department of Prevention, Rehabilitation and Sports medicine, University hospital 'Klinikum rechts der Isar', Technical University of Munich

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2022-02-28
Completion
2022-02-28

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03885102 on ClinicalTrials.gov